হজকিন লিম্ফোমা

The purpose of this study is to compare standard dose radiation of 45 Gray(Gy) in 25 fractions in Non Hodgkin's Lymphoma- Diffuse Large B cell Lymphoma (NHL-DLBCL) to that of 36 Gy in 20 fractions. The role of radiation in NHL-DLBCL has been addressed in large cooperative trials showing improvement in overall survival and progression free survival with combined modality treatment. The doses of radiation used in these trials are heterogeneous ranging from 30-55 Gray(Gy). There is uncertainty about the optimal dose of radiation needed in aggressive lymphomas. A dose response phenomenon is known…

স্পন্সর: Tata Memorial Hospital
ClinicalTrials.gov-এ NCT02964858
রেজিস্ট্রিতে শেষ আপডেট ১১ এপ্রিল ২০২৫ · আমাদের পড়া ২০ অক্টোবর ২০২৬